<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://wealthstar.in/news/lt-significant-order-noida-metro-aqua-line-extension-rs-1000-to-2500-crore-band/</loc>
    <news:news>
      <news:publication><news:name>WealthStar</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-10T04:23:18.261Z</news:publication_date>
      <news:title>L&amp;T wins an order from Noida Metro Rail Corporation worth between ₹1,000 crore and ₹2,500 crore for the Aqua Line extension</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://wealthstar.in/news/jyothy-labs-rs-147-crore-buyback-at-rs-215-per-share-record-date-11-november/</loc>
    <news:news>
      <news:publication><news:name>WealthStar</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-10T04:23:17.680Z</news:publication_date>
      <news:title>Jyothy Labs to buy back its shares at ₹215 each; shareholders on 11 November 2026 are eligible</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://wealthstar.in/news/divis-laboratories-q2-fy27-net-profit-rs-1127-crore-up-64-percent-revenue-rs-3676-crore/</loc>
    <news:news>
      <news:publication><news:name>WealthStar</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-09T06:44:11.200Z</news:publication_date>
      <news:title>Divi's Laboratories Q2 profit is ₹1,127 crore, up 64% from a year earlier; revenue rose 35% to ₹3,676 crore</news:title>
    </news:news>
  </url>
</urlset>
